Metropolis Healthcare Stock Screener | Share Price & Fundamental Analysis
METROPOLIS
Healthcare Service Provider
Screen Metropolis Healthcare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹2029.80
▼
-20.70 (-1.01%)
Share Price BSE
₹2024.90
▼
-26.20 (-1.28%)
Market Cap
₹10,018.74 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
6.87
EPS (TTM)
₹28.29
Dividend Yield
-
Debt to Equity
0.17
52W High
₹2240.00
52W Low
₹1488.60
Operating Margin
18.00%
Profit Margin
8.24%
Revenue (TTM)
₹352.00
EBITDA
₹69.00
Net Income
₹29.00
Total Assets
₹1,867.00
Total Equity
₹1,335.00
Metropolis Healthcare Share Price History - Stock Screener Chart
Screen METROPOLIS historical share price movements with interactive charts. Analyze price trends and patterns.
Metropolis Healthcare Company Profile - Fundamental Screener
Screen Metropolis Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for METROPOLIS shares.
Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical laboratories, including a global reference laboratory in Mumbai, regional reference laboratories, satellite laboratories, and express laboratories. Metropolis provides services to both B2B and B2C markets, covering 197 cities in India and has operations in several African countries. The company offers approximately 3,487 clinical laboratory tests and 530 profiles, and has expanded its network through acquisitions and mergers. Metropolis is known for its quality diagnostics and has received awards for customer service and healthcare excellence.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
Chairperson/CEO
Ameera Sushil Shah
ISIN
INE112L01020
Website
https://www.metropolisindia.com
Metropolis Healthcare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen METROPOLIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 1,867 | 1,555 | 1,502 | 1,530 | 1,004 | 752 | 553 | 530 |
| Current Assets | 346 | 316 | 303 | 393 | 609 | 397 | 305 | 300 |
| Fixed Assets | 1,447 | 1,177 | 1,121 | 1,059 | 343 | 296 | 213 | 207 |
| Liabilities | ||||||||
| Total Liabilities | 1,867 | 1,555 | 1,502 | 1,530 | 1,004 | 752 | 553 | 530 |
| Current Liabilities | 238 | 210 | 246 | 341 | 92 | 58 | 8 | 11 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,335 | 1,099 | 991 | 888 | 708 | 525 | 420 | 429 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 1,313 | 1,086 | 978 | 876 | 696 | 513 | 409 | 405 |
Screen METROPOLIS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 352 | 394 | 430 | 334 | 316 | 353 | 325 | 284 | 280 | 310 | 293 | 312 | 283 | 305 | 292 |
| Expenses | 283 | 296 | 321 | 251 | 235 | 260 | 251 | 212 | 214 | 234 | 226 | 231 | 211 | 221 | 215 |
| EBITDA | 69 | 97 | 109 | 83 | 81 | 93 | 75 | 72 | 66 | 76 | 67 | 81 | 72 | 83 | 77 |
| Operating Profit % | 18.00% | 23.00% | 25.00% | 24.00% | 25.00% | 26.00% | 22.00% | 25.00% | 23.00% | 24.00% | 22.00% | 24.00% | 24.00% | 26.00% | 25.00% |
| Depreciation | 29 | 31 | 32 | 26 | 26 | 27 | 28 | 23 | 21 | 22 | 25 | 18 | 21 | 22 | 23 |
| Interest | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 6 | 6 | 6 | 5 | 6 | 8 | 7 | 6 |
| Profit Before Tax | 36 | 61 | 71 | 51 | 51 | 61 | 42 | 42 | 39 | 48 | 37 | 57 | 43 | 55 | 48 |
| Tax | 7 | 16 | 18 | 14 | 13 | 15 | 11 | 8 | 10 | 13 | 10 | 16 | 9 | 14 | 12 |
| Net Profit | 29 | 45 | 53 | 37 | 38 | 47 | 32 | 34 | 29 | 36 | 27 | 40 | 34 | 41 | 36 |
| EPS | 5.69 | 8.70 | 10.17 | 7.11 | 7.41 | 9.08 | 6.12 | 6.51 | 5.62 | 6.92 | 5.30 | 7.81 | 6.53 | 7.88 | 6.99 |
Metropolis Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen METROPOLIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 263 | 264 | 247 | 253 | 249 | 215 | 90 | 104 | 102 | 91 |
| Investing Activities | -199 | -89 | 48 | -736 | 63 | -104 | 36 | 1 | -86 | 96 |
| Financing Activities | -87 | -181 | -292 | 163 | -33 | -55 | -118 | -87 | -17 | -174 |
| Net Cash Flow | -23 | -6 | 3 | -321 | 279 | 56 | 8 | 18 | -1 | 14 |
Screen METROPOLIS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.90% | 48.89% | 48.89% | 49.67% | 49.62% | 49.43% | 49.40% | 49.75% |
| FII Holding | 15.29% | 12.83% | 12.52% | 18.90% | 18.25% | 18.56% | 16.73% | 0.00% |
| DII Holding | 30.30% | 32.40% | 33.10% | 24.86% | 27.43% | 28.02% | 30.00% | 13.64% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 3.84% | 4.16% | 3.69% | 5.24% | 4.07% | 3.54% | 3.34% | 8.53% |
| Other Holding | 1.68% | 1.72% | 1.80% | 1.33% | 0.63% | 0.45% | 0.53% | 28.08% |
| Shareholder Count | 49,293 | 50,015 | 47,846 | 68,283 | 58,108 | 51,852 | 48,572 | 84,269 |
Metropolis Healthcare Dividend Screener - Share Yield Analysis
Screen METROPOLIS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹4.00 | 0.26% |
| 2023-March | ₹8.00 | 0.46% |
| 2022-March | ₹8.00 | 0.67% |
| 2021-March | ₹8.00 | 0.39% |
| 2020-March | ₹8.00 | 0.36% |
| 2019-March | ₹13.26 | 1.03% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Metropolis Healthcare Index Membership - Market Screener Classification
Screen METROPOLIS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Metropolis Healthcare Market Events Screener - Corporate Actions
Screen METROPOLIS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-11 | 2025-11-11 | Dividend | ₹ 4.00 /share | -3.41% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | 2.62% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 7.95% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 1.82% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 1.03% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 2.86% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | -0.31% |
| 2024-08-21 | 2024-08-21 | Annual General Meeting | NA | -0.32% |
| 2023-11-17 | 2023-11-17 | Dividend | ₹ 4.00 /share | 9.14% |
| 2023-02-23 | 2023-02-23 | Dividend | ₹ 8.00 /share | 4.60% |
| 2022-02-21 | 2022-02-22 | Dividend | ₹ 8.00 /share | -19.67% |
| 2021-02-17 | 2021-02-19 | Dividend | ₹ 8.00 /share | -7.01% |
Metropolis Healthcare Competitors Screener - Peer Comparison
Screen METROPOLIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,700 | 46.83 | 2,555 | 11.28% | 492 | 51.43 |
| Vijaya Diagnostic Centre | 10,881 | 70.34 | 700 | 23.06% | 144 | 61.34 |
| Metropolis Healthcare | 10,019 | 61.96 | 1,346 | 10.64% | 146 | 53.04 |
| Thyrocare Technologies | 7,309 | 56.28 | 702 | 20.80% | 91 | 53.15 |
| Nephrocare Health Services | 4,760 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,379 | 28.37 | 743 | 16.70% | 78 | 46.09 |
| Suraksha Diagnostic | 1,441 | 45.66 | 256 | 15.11% | 31 | 45.86 |
| One Global Service Provider | 1,237 | 28.65 | 148 | 134.60% | 19 | 58.56 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 56.43 |
| Sastasundar Ventures | 1,004 | -103.51 | 1,171 | -18.47% | -134 | 60.55 |
Metropolis Healthcare Company Announcements - News Screener
Screen METROPOLIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Closure of Trading Window | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-21 | Intimation Of Cancellation Of Analyst / Institutional Investor Meeting Scheduled On November 21 2025 | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-05 | Update On Schedule Of Earnings Conference Call For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-04 | Corporate Action-Board approves Dividend | View |
| 2025-11-04 | Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-04 | Board Meeting Outcome for For The Meeting Held Today (November 04 2025) | View |
| 2025-11-04 | Grant Of Stock Benefits | View |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-28 | Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim Dividend If Any For The Financial Year 2025-26 | View |
| 2025-10-13 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Business Update For Q2FY26 | View |
| 2025-09-30 | Closure of Trading Window | View |